FDA approves ranibizumab-hkdz as first interchangeable biosimilar ranibizumab available in both vials and prefilled syringesByModern Retina StaffJune 5th 2026
Retina World Congress 2026: Expanding the DME treatment algorithm beyond anti-VEGFByMichael A. Singer, MD,Sheryl StevensonMay 30th 2026
No 'smoking gun' OCT biomarker found for DME outcomes: Insights from Protocol TByMichael Ip, MD,Martin David HarpMay 26th 2026
Retina World Congress 2026: EYP-1901 phase 2 updates for wet AMD and DMEByAshkan Abbey, MD,Sheryl StevensonMay 23rd 2026